
Leidos Hld (LDOS) Stock Forecast & Price Target
Leidos Hld (LDOS) Analyst Ratings
Bulls say
Leidos Holdings Inc has exhibited a strong financial performance, particularly in its Health & Civil segment, where increased exam volumes have significantly contributed to improved margins. The company's EBIT margins showcased remarkable growth, rising from 14.5% in 2023 to 22.5% in 2024, and the first half of 2025 has seen margins further increase to an impressive 24.3%. Additionally, the anticipated reduction of the Veterans Affairs claims backlog to 60,000 by the end of 2025 is expected to bolster near-term volumes, providing further support for the company's positive financial trajectory.
Bears say
Leidos Holdings Inc. faces a challenging outlook primarily due to projected margin declines in the second half of 2025, significantly compared to the first half of the year. The potential for increased risks associated with the budget environment further exacerbates concerns, as any considerable contraction in margins could negatively impact investor sentiment. Additionally, a significant drop in medical exam volumes poses a substantial risk to the company's margins, which could ultimately weaken its financial position.
This aggregate rating is based on analysts' research of Leidos Hld and is not a guaranteed prediction by Public.com or investment advice.
Leidos Hld (LDOS) Analyst Forecast & Price Prediction
Start investing in Leidos Hld (LDOS)
Order type
Buy in
Order amount
Est. shares
0 shares